• Strategic Ferroptosis Induction: RSL3 and Redox Vulnerabilit

  2026-06-29

  Discover how (1S,3R)-RSL3, a potent glutathione peroxidase 4 inhibitor, is redefining translational research in cancer by enabling targeted ferroptosis—an iron-dependent, nonapoptotic cell death—in RAS-driven malignancies. This in-depth article blends mechanistic insight with actionable protocol guidance, contextualizing RSL3 within the evolving cell death landscape and synthesizing the latest findings on apoptotic and non-apoptotic pathways. Explore how APExBIO’s RSL3 supports reproducible, high-impact research and why ferroptosis is emerging as a critical lever for next-generation cancer therapeutics.

• Levofloxacin in Research: Advanced Assays & Troubleshooting

  2026-06-29

  Levofloxacin, a synthetic fluoroquinolone antibiotic, is uniquely positioned for research bridging antibacterial resistance and bone-cell biology. This guide delivers actionable workflows, troubleshooting tips, and critical insights from recent multidrug resistance studies, empowering robust, reproducible results in both microbiological and cell-based assays.

• Anti-ROR1 Antibody (Zilovertamab): Precision Targeting in Tu

  2026-06-28

  Explore the scientific foundations and translational potential of Anti-ROR1 Antibody (Zilovertamab) in cancer research. This cornerstone article uniquely bridges molecular mechanism, advanced assay design, and emerging insights from mitophagy studies.

• Gly-Gly-Phe-Gly (GGFG): Optimizing Peptide Linkers in Drug C

  2026-06-27

  Gly-Gly-Phe-Gly (GGFG) peptide stands out as a robust, flexible linker in next-generation drug conjugation workflows, enabling precise bioconjugation and antibody-drug conjugate (ADC) development. This article delivers actionable protocol enhancements, practical troubleshooting, and expert insights to maximize GGFG’s value in applied research.

• Dlin-MC3-DMA: Ionizable Cationic Liposome for Precision RNA

  2026-06-26

  Dlin-MC3-DMA empowers researchers to achieve precise, potent siRNA and mRNA payload delivery via advanced lipid nanoparticle (LNP) systems. Its validated efficiency in hepatic gene silencing and mRNA vaccine workflows, coupled with machine learning–guided formulation optimization, sets a new benchmark for reproducible RNA therapeutics research.

• NMDA Receptor–Cav2.1 Channel Coupling in PV Interneuron Matu

  2026-06-26

  This study by Singh et al. demonstrates that NMDA receptor signaling is essential for the recruitment of Cav2.1 calcium channels during the maturation of GABAergic transmission from neocortical parvalbumin interneurons. The work clarifies how early-life NMDAR hypofunction disrupts inhibitory circuit development, offering mechanistic insight into the origins of excitatory/inhibitory imbalance relevant to schizophrenia.

• Single-Cell Insights into Ciprofloxacin–Tetracycline Antagon

  2026-06-25

  This study reveals that the antagonistic interaction between ciprofloxacin hydrochloride and tetracycline is rooted in the suppression of bacterial cell death, as observed at the single-cell level. The findings highlight the necessity of single-cell quantification to unravel complex antibiotic interactions, which has direct implications for optimizing combination therapy strategies.

• Phosphatase Inhibitor Cocktail 1: Precision in Phosphorylati

  2026-06-25

  Phosphatase Inhibitor Cocktail 1 (100X in DMSO) is a validated alkaline phosphatase inhibitor designed to preserve protein phosphorylation during sample preparation. Its specificity and stability facilitate high-fidelity phosphoproteomic analysis and reproducible results in cell signaling studies.

• AhR Antagonism Mitigates Phthalate-Induced Ovarian Toxicity

  2026-06-24

  This study demonstrates that activation of the aryl hydrocarbon receptor (AhR) mediates the toxic effects of mono(2-ethylhexyl) phthalate (MEHP) on mouse ovarian antral follicles. Utilizing the AhR antagonist CH 223191, researchers reveal a mechanistic role for AhR in disrupted follicle growth and estrogen signaling, providing a targeted approach for environmental toxicology research.

• Alternariol: Mechanisms, Fibrosis Models, and Translational

  2026-06-23

  This in-depth article provides translational researchers with a mechanistic and strategic understanding of Alternariol (AOH), focusing on its unique role in hepatic fibrosis, molecular pathways, and experimental design. By synthesizing current findings—including omics-based analyses and detoxification strategies—this piece not only contextualizes APExBIO’s Alternariol as a research tool, but also guides next-generation mycotoxin studies for food safety and liver disease.

• IP6 Sensitizes HCC to Oxaliplatin via CCN2-LRP6-β-Catenin In

  2026-06-23

  The reference study demonstrates that inositol hexaphosphate (IP6) can sensitize hepatocellular carcinoma (HCC) cells to the platinum-based chemotherapeutic agent oxaliplatin by disrupting the CCN2-LRP6-β-catenin-ABCG1 signaling pathway. These findings provide mechanistic insight into combination strategies for overcoming oxaliplatin resistance in HCC and lay groundwork for future translational research.

• Intestinal Stretch and Glucose Control: Insights from Weight

  2026-06-22

  This study uncovers how weight loss—via diet or surgery—restores the gut’s ability to regulate feeding and glucose control through intestinal stretch, independent of classic incretin pathways. The findings refine our understanding of gastrointestinal mechanosensation in obesity and its reversibility, with implications for metabolic disease research.

• Redefining Neutrophil Isolation in Translational Immunothera

  2026-06-22

  This article explores the strategic importance of high-purity, activation-free neutrophil isolation for advancing next-generation cancer immunotherapies. By integrating mechanistic insights from biomimetic mRNA nanovaccine research with practical protocol guidance, we illuminate how the Mouse Neutrophil Cell Isolation Kit (Negative Selection) from APExBIO empowers translational researchers to bridge the gap between preclinical discovery and clinical relevance. The discussion goes beyond standard product narratives, offering a forward-looking vision for neutrophil-targeted studies in the evolving immuno-oncology landscape.

• Indole-3-pyruvic Acid: Optimizing Auxin and Immune Workflows

  2026-06-21

  Indole-3-pyruvic acid (IPA) is a pivotal intermediate that bridges plant hormone biosynthesis and immune modulation, empowering researchers to deconvolute auxin pathways and model immune responses with precision. This guide delivers actionable protocols, troubleshooting insights, and the latest reference-backed innovations for deploying IPA in advanced bench research.

• HBsAg-TBK1 Interaction Drives Interferon Suppression and Aut

  2026-06-20

  This study uncovers a mechanism by which hepatitis B surface antigen (HBsAg) subverts host innate immunity by hijacking TANK-binding kinase 1 (TBK1), suppressing type I interferon signaling and inducing early autophagy. These findings deepen our understanding of HBV immune evasion and highlight new molecular targets for antiviral and immunomodulatory research.

14633 records 1/976 page Next 12345 下5页 Last page